Market Trends of Automated Cell Culture Systems Industry
The Drug Development Segment is Expected to Hold a Significant Market Share Over the Forecast Period
• The drug development segment is expected to increase rapidly because of the increased funding by government bodies in the drug development field during the forecast period. Automated cell culture systems play a crucial role in drug development by providing a controlled and efficient environment for the growth and manipulation of cells. The Department of Health and Human Services (HHS) National Institutes of Health (NIH) is the largest public supporter of biomedical research and development (R&D).
• According to the United States Government Accountability Office, NIH funded multiple R&D activities, with approximately USD 51 billion, contributing to drug development in 2022. The rise in funding can contribute to more research and development activities related to drug development, expanding the market for automated cell culture systems in the coming years.
• Apart from this, the launch of automated cell culture systems with respect to drug development is thriving in the market. For instance, CELLINK launched BIO CELLX to automate 3D cell cultures in March 2022. This product was launched to eliminate the difficulties faced by automating 3D cell-based assays in targeted drug discovery. This would further drive the growth of this particular segment of the market.
• Automated systems enable the rapid screening of thousands of compounds or drug candidates to identify potential leads that interact with a specific target or biological pathway. The above-mentioned factor would help with the significant growth of this segment in the coming years.
North America is Expected to be a Dominant Region Over the Forecast Period
• North America is expected to dominate the automated cell culture systems market during the forecasted period. This can be explained by factors such as the high demand for automated cell culture systems and advancements in cell cultures.
• North America has a significant biopharmaceutical industry, with a high demand for automated cell culture systems to support drug discovery, development, and production processes. Ongoing investments in research and development by pharmaceutical, biotechnology, and academic institutions in North America have driven the adoption of automated cell culture systems for innovative research.
• For instance, in May 2022, the University of Colorado Anschutz Medical Campus announced an investment of around USD 200 million over the following five years to establish a research and treatment center that will aim to develop new therapies, whether regenerative, cellular, or genetic for the treatment of a variety of chronic illnesses. Also, in July 2023, the California Institute for Regenerative Medicine (CIRM) invested approximately USD 50 million to fund clinical-stage research projects. This research will be focused on advancing stem cell and gene therapy treatments. The applicability of automated cell culture systems in cellular therapies, regenerative medicines, and other research areas increases its demand in this region. These parameters would be responsible for fueling the growth of the market in this region.
• The region is a hub for technological innovation, with companies continuously developing advanced automation technologies for cell culture systems, enhancing efficiency and precision. The advances in cell culture using 3D dynamic cell culture systems have been addressed with improvised automated cell culture systems. For instance, Corning launched Organoid Counting Software for the Corning Cell Counter in order to meet the requirements of the researchers working with predictive and complex 3D cell cultures, as mentioned in the articles published on the website in May 2022. The advances in cell cultures may be a major factor in this region's market.
• Therefore, owing to the above-mentioned factors, such as the increased demand for automated cell culture systems and strategic initiatives by market players, growth of the market is expected in the North American region.
